Fig. 1From: Concept and design of a nationwide prospective feasibility/efficacy/safety study of weekly paclitaxel for patients with pathologically confirmed anaplastic thyroid cancer (ATCCJ-PTX-P2)The progress of the present study. Closed bars: Number of institutional registrations (left scale). Open bars: Number of cases registered per month (left scale). Straight line: Projected case accumulation (right scale). Broken line: actual case accumulation (right scale)Back to article page